The Nightmare Quality of Life Questionnaire
A. El-Solh, Yolanda Lawson, Gregory Wilding
Behavioral Sleep Medicine November 27, 2021 DOI: 10.1080/15402002.2021.2008394 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Instrument development and validation study Peer reviewed |
|---|---|
| Sample size | 34 |
| Population | Patients with established nightmares (focus group n = 113; validation cohort n = 34) |
| Duration | Test-retest reliability assessed four weeks apart |
| Measures | Nightmare Quality of Life (NQoL), Nightmare Distress Questionnaire, Nightmare Frequency Questionnaire, SF-36, PSQI |
| Topics | Dreaming |
| Key points | The 16-item Nightmare Quality of Life (NQoL) questionnaire showed good internal consistency (Cronbach's alpha 0.85) and four-week test-retest reliability (ICC = 0.89), with four factors explaining 53.9% of variance. It correlated strongly with the Nightmare Distress Questionnaire (r = 0.87) and more modestly with the Nightmare Frequency Questionnaire (r = 0.69), SF-36 (r = -0.68), and PSQI (r = 0.45). The authors conclude it is a promising multidimensional measure of quality of life in patients with nightmares. |
Abstract
ABSTRACT Rationale Patient-centered outcomes are increasingly sought to evaluate social interactions and healthcare interventions in patients with sleep disorders. Yet, measures to assess quality of life (QoL) are lacking for those who experience nightmares.
Objective: The aim of the study is to describe the development and validation of a new health-related quality of life (HRQoL) instrument for patients with nightmares.
Methods: Attributes obtained from a focus group of patients (n = 113) with established nightmares were analyzed using exploratory factor analysis to elicit salient QoL themes for the new instrument. A validation cohort (n = 34) was used to determine the psychometric performance of the 16-item questionnaire including item-scaling, concurrent validity, and test-retest reliability tested four weeks apart.
Results: Four factors (sleep health, emotional and psychological well-being, social interaction, and motivation) explained 53.9% of the total variance. The Nightmare Quality of Life (NQoL) showed good internal consistency (Cronbach’s alpha 0.85) and test-retest reliability (ICC = 0.89). Concurrent validity was evidenced by a strong correlation with the Nightmare Distress Questionnaire (r = 0.87; p < .001) and more modest associations with the Nightmare Frequency Questionnaire (r = , 0.69; p < .001), SF-36 (r = −0.68; p < .001), and PSQI (r = 0.45; p = .007).
Conclusions: The NQoL has demonstrable construct validity and reliability and represents a promising multi-dimensional instrument to assess outcome measures for quality of life in patients with nightmares.
Citations in the library
Cites 7
- The relationship of nightmare frequency and nightmare distress to well‐being Journal of Sleep Research May 26, 2004
- Aetiology and treatment of nightmare disorder: State of the art and future perspectives Journal of Sleep Research January 29, 2019
- The Nightmare Disorder Index: Development and Initial Validation in a Sample of Nurses. Sleep November 27, 2020
- Management of nightmares in patients with posttraumatic stress disorder: current perspectives. Nature and Science of Sleep November 26, 2018
- Nightmares and Suicide in Posttraumatic Stress Disorder: The Mediating Role of Defeat, Entrapment, and Hopelessness. Journal of Clinical Sleep Medicine March 1, 2016
and 2 more in the library